Cargando…
Beta receptor blocker therapy for the elderly in the COVID-19 era
When the coronavirus disease 2019 (COVID-19) pandemic spread globally from the Hubei region of China in December 2019, the impact on elderly people was particularly unfavorable. The mortality associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was highest in older...
Autores principales: | Santillo, Elpidio, Migale, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403662/ https://www.ncbi.nlm.nih.gov/pubmed/36159512 http://dx.doi.org/10.12998/wjcc.v10.i23.8088 |
Ejemplares similares
-
Levosimendan for Perioperative Cardioprotection: Myth or Reality?
por: Santillo, Elpidio, et al.
Publicado: (2018) -
Patent foramen ovale in an old patient with ischemic stroke following carotid surgery
por: Santillo, Elpidio, et al.
Publicado: (2018) -
Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021) -
Liver injury in the era of COVID-19
por: Cichoż-Lach, Halina, et al.
Publicado: (2021) -
Colorectal cancer screening in the COVID-19 era
por: Kadakuntla, Anusri, et al.
Publicado: (2021)